Institutions / Kotler Kevin

Kotler Kevin

CIK 1601692 · Institution · as of Dec 31, 2025
Portfolio value
$135.37M
Positions
34
As of
Dec 31, 2025

Top holdings

Dec 31, 2025View all 34 →
CompanyClassValueShares% of portfolio
AngioDynamics, Inc.$22.00M1,713,78916.3%
Aurinia Pharmaceuticals Inc.AUPHCommon Stock$19.54M1,224,84614.4%
Avadel Pharmaceuticals PLC$15.98M741,34311.8%
Omeros Corp$15.55M905,63511.5%
NeuroPace Inc$9.75M631,4687.2%
Mediwound Ltd$6.23M337,2364.6%
Axogen, Inc.$5.50M168,0004.1%
Integra Lifesciences Holdings Corp$5.31M427,4453.9%
Aclaris Therapeutics, Inc.$5.13M1,705,9293.8%
Vertical Aerospace Ltd$5.01M939,7053.7%
OraSure Technologies Inc$4.36M1,801,4463.2%
Galapagos NV$2.94M90,0002.2%
ELI LILLY & Co$2.15M2,0001.6%
Cerus Corp$2.08M1,011,6141.5%
NIKE, Inc.$2.04M32,0001.5%
Tectonic Therapeutic, Inc.TECXCommon Stock$1.67M80,0001.2%
Climb Bio, Inc.CLYMCommon Stock$1.60M400,0001.2%
Treace Medical Concepts, Inc.TMCICommon Stock$1.16M474,3650.9%
TriSalus Life Sciences, Inc.$1.01M145,2000.7%
Dexcom Inc$995.5K15,0000.7%
Vanda Pharmaceuticals Inc$882.0K100,0000.7%
Align Technology, Inc.$680.7K4,3590.5%
OnKure Therapeutics, Inc.$573.3K197,6910.4%
General Electric Co$452.2K1,4680.3%
Pulmonx Corp$442.0K200,0000.3%

Activity

Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.